Benitec Biopharma Inc. (BNTC) vs Cabaletta Bio, Inc. (CABA)
A side-by-side comparison of Benitec Biopharma Inc. and Cabaletta Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.94HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
CABA
Cabaletta Bio, Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — BNTC vs CABA
growth of $100 · dividends reinvested · last 7yBNTC -94.3% (-33.6%/yr)CABA -79.2% (-20.1%/yr)CABA compounded faster over this window
BNTC CABA
BNTC vs CABA: by the numbers
- •CABA is the larger company ($328M vs $307M market cap).
Metrics side by side
Valuation
| Metric | BNTC | CABA |
|---|---|---|
| P/B ratio | 1.73 | 1.56 |
Profitability
| Metric | BNTC | CABA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -25.73% | -86.10% |
| ROIC | -28.88% | -85.56% |
Growth (annualized)
| Metric | BNTC | CABA |
|---|---|---|
| Total return CAGR (5Y) | -31.08% | -28.71% |
Frequently asked
- How have BNTC and CABA total returns compared?
- Over the past 5 years, BNTC delivered -31.08% and CABA delivered -28.71% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.